Growth Metrics

Vertex Pharmaceuticals (VRTX) Share-based Compensation (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Revolution Medicines 31.20 Bn 31.20 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.58%
Dec 31, 2025 -19.14%
Sep 30, 2025 16.50%
Jun 30, 2025 0.72%
Mar 31, 2025 -1.01%
Dec 31, 2024 -9.10%
Sep 30, 2024 19.71%
Jun 30, 2024 -19.65%
Mar 31, 2024 -8.01%
Dec 31, 2023 59.36%
Sep 30, 2023 9.72%
Jun 30, 2023 -2.53%
Mar 31, 2023 9.78%
Dec 31, 2022 -17.77%
Sep 30, 2022 19.05%
Jun 30, 2022 -12.59%
Mar 31, 2022 9.87%
Dec 31, 2021 15.15%
Sep 30, 2021 -1.53%
Jun 30, 2021 -9.20%
Mar 31, 2021 18.68%
Dec 31, 2020 -2.48%
Sep 30, 2020 -15.06%
Jun 30, 2020 1.28%
Mar 31, 2020 26.31%
Dec 31, 2019 7.24%
Sep 30, 2019 -4.76%
Jun 30, 2019 -4.38%
Mar 31, 2019 18.81%
Dec 31, 2018 -7.70%
Sep 30, 2018 3.76%
Jun 30, 2018 5.50%
Mar 31, 2018 2.48%
Dec 31, 2017 2.40%
Sep 30, 2017 1.86%
Jun 30, 2017 5.27%
Mar 31, 2017 12.00%
Dec 31, 2016 1.29%
Sep 30, 2016 -1.18%
Jun 30, 2016 11.66%
Mar 31, 2016 24.25%
Dec 31, 2015 -32.08%
Sep 30, 2015 3.91%
Jun 30, 2015 10.24%
Mar 31, 2015 35.40%
Dec 31, 2014 182.45%
Sep 30, 2014 -64.65%
Jun 30, 2014 -8.88%
Mar 31, 2014 99.32%
Dec 31, 2013 22.00%
Sep 30, 2013 -53.68%
Jun 30, 2013 32.21%
Mar 31, 2013 13.17%
Dec 31, 2012 0.20%
Sep 30, 2012 -12.10%
Jun 30, 2012 13.33%
Mar 31, 2012 -4.70%
Dec 31, 2011 -1.22%
Mar 31, 2011 18.26%
Dec 31, 2010 -0.82%
Sep 30, 2010 -2.79%
Jun 30, 2010 26.46%
Mar 31, 2010 9.07%
Dec 31, 2009 -11.96%
Sep 30, 2009 -24.27%
Jun 30, 2009 19.34%